These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3513995)

  • 1. Relationship of concentrations of cholesterol and triglyceride to cyclosporin A in renal transplant patients.
    Yatscoff RW; Rush D; Jeffery JR
    Clin Chem; 1986 Apr; 32(4):700. PubMed ID: 3513995
    [No Abstract]   [Full Text] [Related]  

  • 2. A model to account for the variation in cyclosporin binding to plasma lipids in transplant patients.
    Legg B; Gupta SK; Rowland M
    Ther Drug Monit; 1988; 10(1):20-7. PubMed ID: 3287705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse effect of cyclosporin on plasma cholesterol in renal transplant recipients.
    Raine AE; Carter R; Mann JI; Morris PJ
    Nephrol Dial Transplant; 1988; 3(4):458-63. PubMed ID: 3140134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute serum lipid changes in a renal transplant recipient on intravenous cyclosporin upon administration of an intravenous lipid solution.
    Bolodeoku J; Mellotte GJ
    Postgrad Med J; 1994 Nov; 70(829):849-50. PubMed ID: 7824429
    [No Abstract]   [Full Text] [Related]  

  • 5. Cyclosporin A blood levels are not influenced by dietary alterations in lipids.
    Menon SP; Walker RJ; Duggin GG; Sullivan DR; Horvath JS; Tiller DJ
    Res Commun Chem Pathol Pharmacol; 1991 May; 72(2):203-12. PubMed ID: 1876751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic effects of conversion from cyclosporine to azathioprine in renal transplant recipients.
    Harris KP; Russell GI; Parvin SP; Veitch PS; Walls J
    Proc Eur Dial Transplant Assoc Eur Ren Assoc; 1985; 21():1010-4. PubMed ID: 3887369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of hematocrit on cyclosporine (cyclosporin A) in whole blood and plasma of renal-transplant patients.
    Rosano TG
    Clin Chem; 1985 Mar; 31(3):410-2. PubMed ID: 3882273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Nutritional metabolic progress in patients with a kidney transplant in treatment with low doses of steroids and azathioprine or cyclosporin A].
    Boggio Bertinet D; Triolo G; Costantino A; Colla L; Jaime A; Vercellone A; Segoloni GP; Balzola F
    Minerva Urol Nefrol; 1986; 38(2):191-6. PubMed ID: 3529459
    [No Abstract]   [Full Text] [Related]  

  • 9. Spiramycin does not increase plasma cyclosporin concentrations in renal transplant patients.
    Kessler M; Netter P; Zerrouki M; Renoult E; Trechot P; Dousset B; Jonon B; Mur JM
    Eur J Clin Pharmacol; 1988; 35(3):331-2. PubMed ID: 3053210
    [No Abstract]   [Full Text] [Related]  

  • 10. Cyclosporin-induced renal magnesium leak in renal transplant patients.
    Scoble JE; Freestone A; Varghese Z; Fernando ON; Sweny P; Moorhead JF
    Nephrol Dial Transplant; 1990; 5(9):812-5. PubMed ID: 2129356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood-to-plasma distribution of cyclosporin A in a renal transplant recipient.
    Shibata N; Minouchi T; Hayashi Y; Shibata H; Ono T; Shimakawa H
    Eur J Clin Pharmacol; 1988; 35(4):443-4. PubMed ID: 3058487
    [No Abstract]   [Full Text] [Related]  

  • 12. Lipid abnormalities in renal transplant recipients treated with cyclosporine.
    Vathsala A; Weinberg RB; Schoenberg L; Grevel J; Dunn J; Goldstein RA; Van Buren CT; Lewis RM; Kahan BD
    Transplant Proc; 1989 Aug; 21(4):3670-3. PubMed ID: 2669278
    [No Abstract]   [Full Text] [Related]  

  • 13. Prospective evaluation of changes in lipid profiles in cyclosporine-treated renal transplant patients.
    Markell MS; Brown CD; Butt KM; Friedman EA
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1497-9. PubMed ID: 2652482
    [No Abstract]   [Full Text] [Related]  

  • 14. Hyperbilirubinaemia and cyclosporin A levels in renal transplant patients.
    Loertscher R; Wenk M; Harder F; Brunner F; Follath F; Thiel G
    Lancet; 1981 Sep; 2(8247):635-6. PubMed ID: 6116111
    [No Abstract]   [Full Text] [Related]  

  • 15. Influence of nicardipine on renal function and plasma cyclosporin in renal transplant patients.
    Kessler M; Netter P; Renoult E; Jonon B; Mur JM; Trechot P; Dousset B
    Eur J Clin Pharmacol; 1989; 36(6):637-8. PubMed ID: 2673796
    [No Abstract]   [Full Text] [Related]  

  • 16. Low cyclosporin A blood levels and acute graft rejection in a renal transplant recipient during rifampin treatment.
    Offermann G; Keller F; Molzahn M
    Am J Nephrol; 1985; 5(5):385-7. PubMed ID: 3904451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic range of cyclosporin in renal transplant patients by specific monoclonal radioimmunoassay.
    Kwan JT; Foxall PJ; Townend JN; Thick MG; Bending MR; Eisinger AJ
    Lancet; 1987 Oct; 2(8565):962-3. PubMed ID: 2889874
    [No Abstract]   [Full Text] [Related]  

  • 18. High dose methylprednisolone increases plasma cyclosporin levels in renal transplant recipients.
    Klintmalm G; Säwe J
    Lancet; 1984 Mar; 1(8379):731. PubMed ID: 6143058
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of topical rifamycin SV treatment on cyclosporin A blood levels in a renal transplant recipient.
    Renoult E; Hubert J; Trechot P; Hestin D; Kessler M; L'Hermite J
    Eur J Clin Pharmacol; 1991; 40(4):433-4. PubMed ID: 2050183
    [No Abstract]   [Full Text] [Related]  

  • 20. Steroid withdrawal in cyclosporine-treated living related donor renal transplant recipients.
    Kupin W; Venkat KK; Oh HK
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1623-4. PubMed ID: 2652528
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.